Lyell Immunopharma Q1 2026 Earnings Narrower Loss Surprises Expectations Amid Clinical Progress 51Talk COE Q3 2025 Earnings Net Loss Widens as Stock Declines Amid Quiet Quarter NUVB Q1 2026 Earnings Narrow EPS Beat Reflects Continued Pipeline Progress GOTU Q4 2025 Earnings EPS Beat Estimates by 419 Amid Challenging Environment LINC Q1 2026 Earnings EPS Surpasses Estimates by Over 21 Stock Rises Highland Global Allocation Fund HGLB Slips 091 Holding Within Established Trading Range ADAMH Steady Near Par Adamas Senior Notes Hold Ground Amid Low Volatility Digital Asset Acquisition Corp Units DAAQU Slips 057 as SPAC Units Trade Near Support Ocugen Inc OCGN Holds Steady at 134 Amid Consolidation Key Levels in Focus Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD